Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04531397
Recruitment Status : Withdrawn (lack of funding)
First Posted : August 28, 2020
Last Update Posted : December 29, 2020
Sponsor:
Information provided by (Responsible Party):
Children's Hospital of Fudan University

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : June 1, 2022
Estimated Study Completion Date : December 31, 2022